Phase II Trial of Cisplatin, Gemcitabine, and Bevacizumab As First-Line Therapy for Metastatic Urothelial Carcinoma: Hoosier Oncology Group GU 04-75

标题
Phase II Trial of Cisplatin, Gemcitabine, and Bevacizumab As First-Line Therapy for Metastatic Urothelial Carcinoma: Hoosier Oncology Group GU 04-75
作者
关键词
-
出版物
JOURNAL OF CLINICAL ONCOLOGY
Volume 29, Issue 12, Pages 1525-1530
出版商
American Society of Clinical Oncology (ASCO)
发表日期
2011-03-22
DOI
10.1200/jco.2010.31.6067

向作者/读者发起求助以获取更多资源

Discover Peeref hubs

Discuss science. Find collaborators. Network.

Join a conversation

Create your own webinar

Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.

Create Now